Clinical decisions
Diagnosis, prescribing, medication changes, clinical interpretation, and urgent safety response stay with your licensed team.
How Rely works / Safety and governance
Rely routes novel cases to review and releases workflow changes only after testing, approval, and monitoring.
New behavior moves through review, testing, approval, deployment, and monitoring.
Novel clinical cases go to human review. The model does not expand its own authority.
A production change has to earn its way through. New behavior moves through review, testing, approval, deployment, and monitoring. The diagram shows Change proposed, Risk and scope reviewed, Cases tested, Owner approves, Controlled release, Monitor or roll back. Novel clinical cases go to human review. The model does not expand its own authority.
Boundaries
Diagnosis, prescribing, medication changes, clinical interpretation, and urgent safety response stay with your licensed team.
An unusual case enters review; it does not create a new rule.
If a dependency fails, the configured fallback runs and the owner stays visible.
A reviewed trace, exception, or operating result supports a written change.
The proposal is tested against routine cases, edge cases, stops, and fallbacks.
The accountable clinical or operational owner approves the change before a bounded release.
The changed path is watched for regressions and rolled back when it does not behave as approved.
Clearance
Company security posture does not clear a workflow. Each program separately approves its data, communications, clinical boundary, testing, fallbacks, and monitoring.
Agree the boundary, escalation path, and clearance list before setting a launch date.